|
1
|
Górriz JL, Molina P, Cerverón MJ, Vila R,
Bover J, Nieto J, Barril G, Martínez-Castelao A, Fernández E,
Escudero V, et al: Vascular calcification in patients with
nondialysis CKD over 3 years. Clin J Am Soc Nephrol. 10:654–666.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Emerging Risk Factors Collaboration, ;
Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio
E, Ingelsson E, Lawlor DA, Selvin E, et al: Diabetes mellitus,
fasting blood glucose concentration, and risk of vascular disease:
A collaborative meta-analysis of 102 prospective studies. Lancet.
375:2215–2222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
London GM, Guérin AP, Marchais SJ,
Métivier F, Pannier B and Adda H: Arterial media calcification in
end-stage renal disease: Impact on all-cause and cardiovascular
mortality. Nephrol Dial Transplant. 18:1731–1740. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mizobuchi M, Tower D and Slatopolsky E:
Vascular calcification: The killer of patients with chronic kidney
disease. J Am Soc Nephrol. 20:1453–1464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hruska K, Mathew S, Lund R, Qiu P and
Pratt R: Hyperphosphatemia of chronic kidney disease. Kidney Int.
74:148–157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Demer L and Tintut Y: Vascular
calcification: Pathobiology of a multifaceted disease. Circulation.
117:2938–2948. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Giachelli CM: Vascular calcification
mechanisms. J Am Soc Nephrol. 15:2959–2964. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhan JK, Tan P, Wang YJ, Wang Y, He JY,
Tang ZY, Huang W and Liu YS: Exenatide can inhibit calcification of
human VSMCs through the NF-kappaB/RANKL signaling pathway.
Cardiovasc Diabetol. 13:1532014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu F, Zhong H, Liang JY, Fu P, Luo ZJ,
Zhou L, Gou R and Huang J: Effect of high glucose levels on the
calcification of vascular smooth muscle cells by inducing
osteoblastic differentiation and intracellular calcium deposition
via BMP-2/Cbfα-1 pathway. J Zhejiang Univ Sci B. 11:905–911. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Steitz SA, Speer MY, Curinga G, Yang HY,
Haynes P, Aebersold R, Schinke T, Karsenty G and Giachelli CM:
Smooth muscle cell phenotypic transition associated with
calcification: Upregulation of Cbfα1 and downregulation of smooth
muscle lineage markers. Circ Res. 89:1147–1154. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Speer MY, Li X, Hiremath PG and Giachelli
CM: Runx2/Cbfα1, but not loss of myocardin, is required for smooth
muscle cell lineage reprogramming toward osteochondrogenesis. J
Cell Biochem. 110:935–947. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J, Zheng B, Zhou PP, Zhang RN, He M,
Yang Z and Wen JK: Vascular calcification is coupled with
phenotypic conversion of vascular smooth muscle cells through
Klf5-mediated transactivation of the Runx2 promoter. Biosci Rep.
34:e001482014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li X, Yang H and Giachelli CM: Role of the
sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth
muscle cell calcification. Circ Res. 98:905–912. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Villa-Bellosta R, Levi M and Sorribas V:
Vascular smooth muscle cell calcification and SLC20 inorganic
phosphate transporters. Effects of PDGF, TNF-alpha, and Pi Pflugers
Arch. 458:1151–1161. 2009. View Article : Google Scholar
|
|
15
|
Lau WL, Festing MH and Giachelli CM:
Phosphate and vascular calcification: Emerging role of the
sodium-dependent phosphate co-transporter Pit-1. Thromb Haemost.
104:464–470. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang H, Curinga G and Giachelli CM:
Elevated extracellular calcium levels induce smooth muscle cell
matrix mineralization in vitro. Kidney Int. 66:2293–2299. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kidney Disease: Improving Global Outcomes
(KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for
the evaluation and management of chronic kidney disease. Kidney
Int. (Suppl 3):S1–S150. 2013.
|
|
18
|
Yokozawa T, Zheng PD, Oura H and Koizumi
F: Animal model of adenine-induced chronic renal failure in rats.
Nephron. 44:230–234. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoshida T, Yamashita M and Hayashi M:
Kruppel-like factor 4 contributes to high phosphate-induced
phenotypic switching of vascular smooth muscle cells into
osteogenic cells. J Biol Chem. 287:25706–25714. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jardine MJ, Hata J, Woodward M, Perkovic
V, Ninomiya T, Arima H, Zoungas S, Cass A, Patel A, Marre M, et al:
Prediction of kidney-related outcomes in patients with type 2
diabetes. Am J Kidney Dis. 60:770–778. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wan EYF, Fong DYT, Fung CSC, Yu EYT, Chin
WY, Chan AKC and Lam CLK: Prediction of new onset of end stage
renal disease in Chinese patients with type 2 diabetes mellitus-a
population-based retrospective cohort study. BMC Nephrol.
18:2572017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yoshida T, Yamashita M, Horimai C and
Hayashi M: High glucose concentration does not modulate the
formation of arterial medial calcification in experimental uremic
rats. J Vasc Res. 50:512–520. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen NX, Duan D, O'Neill KD and Moe SM:
High glucose increases the expression of Cbfa1 and BMP-2 and
enhances the calcification of vascular smooth muscle cells. Nephrol
Dial Transplant. 21:3435–3442. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miyamoto K, Haito-sugino S, Kuwahara S,
Ohi A, Nomura K, Ito M, Kuwahata M, Kido S, Tatsumi S, Kaneko I and
Segawa H: Sodium-dependent phosphate cotransporters: Lessons from
gene knockout and mutation studies. J Pharm Sci. 100:3719–3730.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suzuki A, Ghayor C, Guicheux J, Magne D,
Quillard S, Kakita A, Ono Y, Miura Y, Oiso Y, Itoh M and Caverzasio
J: Enhanced expression of the inorganic phosphate transporter Pit-1
is involved in BMP-2-induced matrix mineralization in
osteoblast-like cells. J Bone Miner Res. 21:674–683. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Voelkl J, Alesutan I, Leibrock CB,
Quintanilla-Martinez L, Kuhn V, Feger M, Mia S, Ahmed MS,
Rosenblatt KP, Kuro-O M and Lang F: Spironolactone ameliorates
PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice.
J Clin Invest. 123:812–822. 2013.PubMed/NCBI
|
